News blog

Byotrol

• BY: Andrew Hore |
• POSTED: 20/11/2012 |

Antimicrobial technology developer Byotrol continues to grow revenues and make progress towards break even. 

Product sales grew 11% to £1.03m in the six months to September 2012. Food and beverage-related sales in the UK were 88% ahead. Gross profit margin in 34%. Revenues from the project with Kimberly-Clark are not included in the headline revenues because the agreement is with the Byotrol Consumer Products joint venture, which made a positive contribution thanks to the deal. Group operating costs were reduced by one-third. The reported loss fell from £1.38m to £677,000.

There was £782,000 in the bank at the end of September 2012, following a £799,000 cash outflow from operations. The cash outflow should be stemmed in the second half.

Byotrol’s technology can be used in a wide range of products. It has low toxicity and kills bacteria, viruses and other microbes. Sainsbury’s has launched a pet product range using Byotrol technology and Rentokil Initial has launched UltraProtect, which is co-branded.

Higher than expected second half operating costs mean that house broker finnCap has increased its forecast for the year to March 2013 from £569,000 to £731,000. That points to a small second half loss. A profit is still forecast for 2013-14.

Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFNovember2012_38.pdf